Loading
Further markers of endothelial dysfunction / Hypertensive Disorder of Pregnancy / Preeclampsia (PE) · Observational Study
ClinicalTrials.gov · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective observational registry record for an ongoing study evaluating hyperspectral imaging as a diagnostic and prognostic marker in preeclampsia. No results are currently reported; the study is actively recruiting participants and has not yet generated outcome data.
Observational. Preeclampsia (PE), Hypertensive Disorder of Pregnancy; Female; age from 18 Years; accepts healthy volunteers. Intervention: Preeclampsia; Pregnancy induced Hypertension and chronic Hypertension; Normotensive pregnant control group; Non-pregnant control group. n = 385. 1 site: Germany.
This is a prospective observational registry record for an ongoing study evaluating hyperspectral imaging as a diagnostic and prognostic marker in preeclampsia. No results are currently reported; the study is actively recruiting participants and has not yet generated outcome data.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is an ongoing observational registry study with no results reported; it aims to evaluate a novel diagnostic technology in preeclampsia but remains in the recruitment phase.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06912477). This is a study registration, not published results. Lead sponsor: Heidelberg University. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 385 participants (ESTIMATED). Conditions: Preeclampsia (PE), Hypertensive Disorder of Pregnancy. Interventions: DIAGNOSTIC_TEST: Hyperspectral imaging; DIAGNOSTIC_TEST: Further markers of endothelial dysfunction. Primary outcome measures: Time Until Delivery , observation period until 6 months after delivery. Brief summary: Preeclampsia is a pregnancy-specific hypertensive disorder and can progress rapidly to severe adverse outcomes affecting both the mother and the fetus. Endothelial and microcirculatory dysfunction mediate systemic preeclampsia-related organ dysfunctions. Changes in endothelial and vascular function in preeclampsia have been demonstrated through reduced flow-mediated vasodilation as a result of reduced availability of nitric oxide, which potentially persists up to several years postpartum. Hyperspectral imaging is a new innovative technology that allows to assess the peripheral microcirculation and perfusion non-invasively and contactless, but has never been evaluated in the context of preeclampsia before. This EPICS project (Endothelial dysfunction for Prognosis In patients with preeClampSia) is a prospective observational study and aims to investigate hyperspectral imaging as a new potential diagnostic and prognostic marker in preeclampsia.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.